Related references
Note: Only part of the references are listed.In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
Khurshida Begum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
William O'Riordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Omadacycline for Community-Acquired Bacterial Pneumonia
Roman Stets et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic
Steven Opal et al.
CLINICAL INFECTIOUS DISEASES (2019)
Microbiology and Preclinical Review of Omadacycline
James A. Karlowsky et al.
CLINICAL INFECTIOUS DISEASES (2019)
Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
Joshua P. Metlay et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial
William O'Riordan et al.
LANCET INFECTIOUS DISEASES (2019)
Omadacycline Gut Microbiome Exposure Does Not Induce Clostridium difficile Proliferation or Toxin Production in a Model That Simulates the Proximal, Medial, and Distal Human Colon
Ines B. Moura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers
A. McLure et al.
EPIDEMIOLOGY AND INFECTION (2019)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection
M. L. Davis et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis
Raseen Tariq et al.
CLINICAL INFECTIOUS DISEASES (2018)
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam et al.
CLINICAL INFECTIOUS DISEASES (2016)
Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia
James D. Chalmers et al.
JOURNAL OF INFECTION (2016)
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Dennis L. Stevens et al.
CLINICAL INFECTIOUS DISEASES (2014)
Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
Kevin A. Brown et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Models for the study of Clostridium difficile infection
Emma L. Best et al.
GUT MICROBES (2012)
Share Paper
